ArticleFrontiers in immunology2019

Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies.

Falk Diedrichs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.